Question: Exercise 2-20 (Algo) Worksheet [Appendix 2A] Skip to question [The following information applies to the questions displayed below.] The December 31, 2021, unadjusted trial balance
Exercise 2-20 (Algo) Worksheet [Appendix 2A]
Skip to question
[The following information applies to the questions displayed below.]
The December 31, 2021, unadjusted trial balance for the Wolkstein Drug Company is presented below. December 31 is the companys year-end reporting date.
| Account Title | Debits | Credits | |
| Cash | 77,610 | ||
| Accounts receivable | 20,750 | ||
| Prepaid rent | 2,200 | ||
| Inventory | 31,250 | ||
| Equipment | 54,000 | ||
| Accumulated depreciation | 16,200 | ||
| Accounts payable | 21,000 | ||
| Salaries payable | 0 | ||
| Common stock | 100,000 | ||
| Retained earnings | 11,500 | ||
| Sales revenue | 343,000 | ||
| Cost of goods sold | 205,800 | ||
| Salaries expense | 68,600 | ||
| Rent expense | 13,200 | ||
| Depreciation expense | 0 | ||
| Utilities expense | 13,720 | ||
| Advertising expense | 4,570 | ||
| Totals | 491,700 | 491,700 | |
The following year-end adjusting entries are required:
- Depreciation expense for the year on the equipment is $5,400.
- Salaries at year-end should be accrued in the amount of $4,520.
Exercise 2-20 (Algo) Part 1
Required: 1. Prepare and complete a worksheet.
Step by Step Solution
There are 3 Steps involved in it
Get step-by-step solutions from verified subject matter experts
